Household products giant Reckitt Benckiser has agreed to pay a fine of £10.2m after admitting to abusing its market position for the supply of heartburn drug Gaviscon.
The Office of Fair Trading (OFT) had accused the firm in February of restricting competition in the supply of heartburn medicines to the NHS.
The OFT said the fine had been reduced from £12m.
This reflected Reckitt's admission and early co-operation with the OFT.
The OFT's inquiry followed an investigation by the BBC's Newsnight programme in 2008
via bbc.co.uk
No comments:
Post a Comment